Tyra Biosciences, Inc.

Tyra Biosciences, Inc.

TYRA · Nasdaq

Tyra Biosciences, Inc. (TYRA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Tyra Biosciences, Inc. in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 83 days

EPS estimate

-0.66

Revenue estimate

0

Past earnings

04 Aug 2026
EPS actual
-0.69 (-6.2%)
estimate -0.65
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 May 2026
EPS actual
-0.64 (-8.8%)
estimate -0.59
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
02 Mar 2026
EPS actual
-0.57 (-7.2%)
estimate -0.53
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Tyra Biosciences missed consensus estimates on EPS, with EPS of -$0.69 versus an estimate of -$0.6499, while revenue met expectations at $0. In the prior quarter, EPS also missed estimates and revenue likewise met expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Todd Harris
Employees
60
IPO date
15 Sep 2021
ISIN
US90240B1061
Website
tyra.bio

Frequently asked questions

When does Tyra Biosciences, Inc. (TYRA) next report earnings?

Tyra Biosciences, Inc. (TYRA) is scheduled to report earnings on November 11, 2026.

What was Tyra Biosciences, Inc.'s most recent earnings date?

Tyra Biosciences, Inc. (TYRA) last reported earnings on August 4, 2026.

Where is Tyra Biosciences, Inc. stock listed?

Tyra Biosciences, Inc. (TYRA) is listed on Nasdaq.